Second-line treatment of T790M-negative non-small cell lung cancer patients

by Bin-Chi Liao, Sebastian Griesing, James Chih-Hsin Yang
Published 2019-11-01

First-line afatinib for the treatment of mutation-positive non-small-cell lung cancer in the ‘real-world’ clinical setting

by Keunchil Park, Darren Wan-Teck Lim, Isamu Okamoto, James Chih-Hsin Yang
Published 2019-04-01

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

by Shang-Gin Wu, Chong-Jen Yu, James Chih-Hsin Yang, Jin-Yuan Shih
Published 2020-08-01

Treating patients with -positive non-small cell lung cancer: latest evidence and management strategy

by Bin-Chi Liao, Chia-Chi Lin, Jin-Yuan Shih, James Chih-Hsin Yang
Published 2015-09-01

The Inhibition of Wnt Restrain KRAS^G12V-Driven Metastasis in Non-Small-Cell Lung Cancer

by Pei-Shan Hung, Ming-Hung Huang, Yuan-Yeh Kuo, James Chih-Hsin Yang
Published 2020-03-01

The Role of Interleukin 1β in the Pathogenesis of Lung Cancer

by Edward B. Garon, MD, James Chih-Hsin Yang, MD, PhD, Steven M. Dubinett, MD
Published 2020-03-01

Circulating Exosomal Integrin β3 Is Associated with Intracranial Failure and Survival in Lung Cancer Patients Receiving Cranial Irradiation for Brain Metastases: A Prospective Obse...

by Guann-Yiing Chen, Jason Chia-Hsien Cheng, Ya-Fang Chen, James Chih-Hsin Yang, Feng-Ming Hsu
Published 2021-01-01

Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients – A Taiwanese study

by Ting-Hui Wu, Lukas Jyuhn-Hsiarn Lee, Chang-Tsu Yuan, Tom Wei-Wu Chen, James Chih-Hsin Yang
Published 2019-01-01

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer

by Shao-Lun Lu, Feng-Ming Hsu, Kuan-Yu Chen, Chao-Chi Ho, James Chih-Hsin  Yang, Jason Chia-Hsien Cheng
Published 2016-08-01

Enhancing Anticancer Effect of Gefitinib across the Blood–Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80

by Kuan-Hung Lin, Shu-Ting Hong, Hsiang-Tsui Wang, Yu-Li Lo, Anya Maan-Yuh Lin, James Chih-Hsin Yang
Published 2016-11-01

Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides

by Shu-Ting Hong, Huaching Lin, Chen-Shen Wang, Chih-Hsien Chang, Anya Maan-Yuh Lin, James Chih-Hsin Yang, Yu-Li Lo
Published 2019-08-01

Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.

by Mei-Chuan Tang, Mei-Yi Wu, Ming-Hung Hwang, Ya-Ting Chang, Hui-Ju Huang, Anya Maan-Yuh Lin, James Chih-Hsin Yang
Published 2015-01-01

The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases.

by Yun Chiang, James Chih-Hsin Yang, Feng-Ming Hsu, Yu-Hsuan Chen, Jin-Yuan Shih, Zhong-Zhe Lin, Keng-Hsueh Lan, Ann-Lii Cheng, Sung-Hsin Kuo
Published 2015-01-01

Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size.

by Zhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, Yu-Yun Shao, Yi-Chun Yeh, Raymond Nien-Chen Kuo, Chih-Hung Hsu, James Chih-Hsin Yang, Ann-Lii Cheng, Mei-Shu Lai
Published 2013-01-01

Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer

by Wen-Chi Yang, Feng-Ming Hsu, Yu-Hsuan Chen, Jin-Yuan Shih, Chong-Jen Yu, Zhong-Zhe Lin, Szu-Huai Lu, James Chih-Hsin Yang, Ann-Lii Cheng, Sung-Hsin Kuo
Published 2020-05-01

Lysine Deprivation Induces AKT-AADAT Signaling and Overcomes EGFR-TKIs Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer Cells

by Chia-Chi Hsu, Albert Ying-Po Yang, Jui-Yi Chen, Hsin-Hui Tsai, Shu-Heng Lin, Pei-Chen Tai, Ming-Hung Huang, Wei-Hsun Hsu, Anya Maan-Yuh Lin, James Chih-Hsin Yang
Published 2021-01-01

Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors

by Bin-Chi Liao, Ya-Ying Bai, Jih-Hsiang Lee, Chia-Chi Lin, Shu-Yung Lin, Yee-Fan Lee, Chao-Chi Ho, Jin-Yuan Shih, Yeun-Chung Chang, Chong-Jen Yu, James Chih-Hsin Yang, Pan-Chyr Yang
Published 2018-04-01

Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unit

by Emily Han-Chung Hsiue, Pei-Lin Lee, Yung-Hsuan Chen, Ting-Hui Wu, Chiao-Feng Cheng, Keng-Man Cheng, Po-Chun Yang, Hsing-Wu Chen, Pei-Yu Lin, Dai-Lung Chiang, Huey-Dong Wu, James Chih-Hsin Yang, Chong-Jen Yu
Published 2019-06-01

Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan

by Yuh-Min Chen, James Chih-Hsin Yang, Wu-Chou Su, Inn-Wen Chong, Te-Chun Hsia, Meng-Chih Lin, Gee-Chen Chang, Chao-Hua Chiu, Chao-Chi Ho, Shang-Yin Wu, Jen-Yu Hung, Chin-Chou Wang, Tsung-Ying Yang, Chong-Jen Yu
Published 2020-12-01

Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC T...

by James Chih-Hsin Yang, MD, PhD, Tony S.K. Mok, MD, Shun Lu, MD, Kazuhiko Nakagawa, MD, PhD, Nobuyuki Yamamoto, MD, Yuan-Kai Shi, MD, Li Zhang, MD, Ross A. Soo, M.B.B.S., PhD, Satoshi Morita, PhD, Tomohide Tamura, MD
Published 2021-03-01